ConcertAI

Overview

Oncology-focused real-world data and AI company maintaining one of the industry's largest independent oncology research databases combining clinical, molecular, claims, and imaging data. Provides SaaS solutions and RWE services to life sciences companies, CROs, medical societies, and regulators in the US, Europe, and Japan.

Notable

Raised a $150M Series C from Sixth Street at a $1.9B valuation (2022); partnerships include Janssen and Bristol Myers Squibb; serves 45+ life sciences companies and CROs.

Key services

oncology real-world datasets (clinico-genomic, claims-linked)
eurekaHealth / CARA AI software platform
RWE study services and external control arms
clinical trial optimization analytics

Subcategories

Oncology Rwd
EHR Data
RWE Software

Verified Reviews

No verified reviews yet — are you a customer of ConcertAI? Share your experience in a short, confidential interview.

Share your experience

Sources

https://www.fiercehealthcare.com/health-tech/concertai-hits-19b-valuation-150m-series-c-real-world-data-cancer-research-tools
https://www.prnewswire.com/news-releases/life-sciences-and-healthcare-leader-concertai-raises-150-million-series-c-from-sixth-street-at-1-9-billion-valuation-301512389.html
https://www.concertai.com/